Spiropiperidine derivatives as NK3 antagonists

Details for Australian Patent Application No. 2008203707 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Vifian, Walter; Ratni, Hasane; Caroon, Joanie Marie; Dillon, Michael Patrick; Nettekoven, Matthias; Han, Bo

Agent Spruson & Ferguson

Pub. Number AU-B-2008203707

PCT Pub. Number WO2008/081012

Priority 07100064.0 03.01.07 EP

Filing date 2 January 2008

Wipo publication date 10 July 2008

Acceptance publication date 21 June 2012

International Classifications

C07D 498/10 Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/537 - spiro-condensed or forming part of bridged ring systems

A61P 25/00 Drugs for disorders of the nervous system

Event Publications

23 July 2009 PCT application entered the National Phase

  PCT publication WO2008/081012 Priority application(s): WO2008/081012

21 June 2012 Application Accepted

  Published as AU-B-2008203707

18 October 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008203708-Use of somatostatin analogs in cluster headache

2008203703-Method of providing disease-specific binding molecules and targets